Brukinsa zanubrutinib

Dec 2021: BRUKINSA (Zanubrutrinib) magani ne na likitanci daga BeiGene ltd Ana amfani da BRUKINSA don bi da manya da Mantle cell lymphoma (MCL), Waldenström's macroglobulinemia (WM) da lymphoma na yanki na gefe (MZL) waɗanda suka sami akalla sau ɗaya a baya. ciwon daji magani. Waldenström's macroglobulinemia wani nau'in macroglobulinemia ne wanda Waldenström's (WM) ya haifar. Marasa lafiya na iya saya Brukinsa online.

Lokacin da aka ɗauka a adadin adadin yau da kullun na 320 MG, BRUKINSA® (zanubrutinib) an gano ya toshe kashi 100 na BTK a cikin ƙwayoyin jini da kashi 94 zuwa kashi 100 na BTK a cikin ƙwayoyin lymph. Har yanzu ba a tantance tasirin hana BTK gabaɗaya akan sakamakon jiyya ba.

BRUKINSA magani ne ga mutanen da suka sami aƙalla magani ɗaya na farko don maganin lymphoma na mantle cell (MCL).

Amincewar BRUKINSA ya dogara ne akan ƙimar amsawa. Har yanzu ana kimanta wannan amfani don ganin ko yana da wani fa'idar asibiti. BRUKINSA ba a san yana da aminci ko tasiri a cikin yara ba.

Sunan furotin Bruton's tyrosine kinase (BTK) yana da alaƙa da MCL.

Me yasa mai hana BTK ke taimakawa wajen maganin lymphoma na mantle cell (MCL)?

MCL yana haifar da mummunan ƙwayoyin B waɗanda ke yaduwa kuma suna yaduwa da sauri.
BTK (Bruton's tyrosine kinase) furotin ne wanda ke taimakawa ƙwayoyin B masu cutarwa girma da yaduwa ta hanyar aika musu da sakonni.
Toshewar BTK na iya taimakawa wajen hana wannan sigina.
Har yanzu ba a tantance tasirin hana BTK gabaɗaya akan sakamakon jiyya ba.

Yaya Brukinsa yake aiki sosai?

A cikin karatun asibiti guda biyu, 118 marasa lafiya tare da MCL sun karɓi BRUKISA bayan aƙalla 1 kafin magani. A cikin duka karatun asibiti, 84% marasa lafiya sun amsa magani, wanda aka sani da ƙimar amsa gabaɗaya kuma kusan 80% sun ci gaba da amsawa tsawon shekara ɗaya ko fiye. 

Menene illar da Brukinsa ke yi?

BRUKINSA na iya haifar da mummunar illa, gami da:

Zubar da jini matsalar zubar jini ce mai hatsarin gaske wacce zata iya kaiwa ga mutuwa. Idan kuma kuna shan maganin kashe jini, haɗarin zubar jini na iya ƙaruwa. Idan kuna da wasu alamu ko alamun jini, gaya wa likitan ku, gami da:

• jini a cikin kujerun ku ko kuma baƙin baƙar fata (kama da kwalta)
• fitsari mai ruwan hoda ko ruwan kasa
• zub da jini ba zato ba tsammani, ko zubar jini mai tsanani ko ba za ku iya sarrafawa ba
• amai jini ko amai wanda yayi kama da kayan kofi
• tari da jini ko daskarewar jini
• ƙara rauni
• dizziness
• rashin ƙarfi
• rikicewa
• canje-canje a cikin magana
• ciwon kai wanda ke dadewa.

Cututtuka hakan na iya zama mai tsanani kuma yana iya haifar da mutuwa. Faɗa wa likitanka nan da nan idan kana da zazzaɓi, sanyi, ko alamomin mura.

• Raguwa a cikin ƙididdigar ƙwayoyin jini. Rage kididdigar jini (fararen ƙwayoyin jini, platelets, da jajayen ƙwayoyin jini) suna da yawa tare da BRUKISA, amma kuma yana iya zama mai tsanani. Ya kamata mai ba da lafiyar ku ya yi gwajin jini yayin jiyya tare da BRUKINSA don duba adadin jinin ku.
• Ciwon daji na farko na biyu. Sabbin cututtukan daji sun faru a cikin mutane yayin jiyya da brukinsa, gami da kansar fata. Yi amfani da kariya ta rana lokacin da kake waje a cikin hasken rana.
• Matsalolin bugun zuciya (atrial fibrillation da atrial flutter). Faɗa wa ma'aikacin lafiyar ku idan kuna da ɗaya daga cikin alamun ko alamu masu zuwa:
  
  • bugun zuciyar ka yana da sauri ko mara tsari
  • jin annurin kai ko damuwa
  • wucewa (suma)
  • rashin ƙarfi na numfashi
  • rashin jin kirji

Yaya ake ɗaukar Brukinsa?

Matsakaicin shawarar BRUKINSA shine 320 MG kowace rana, wanda shine capsules na 80-MG guda huɗu. Likitanka na iya ba da shawarar shan brukinsa: sau biyu a rana ko sau ɗaya kowace rana.

Ya kamata a sha maganin brukinsa gabaɗaya da ruwa - kar a buɗe, karya, ko tauna. Ana iya shan BRUKINSA tare da abinci ko babu.

Ana iya canza adadin ku da jadawalin ku ko kuma a katse shi Likitan ku don biyan buƙatun ku na kowane ɗayanku gami da sarrafa illolin.

Bayyanai 

Amincewa kamar yadda Dec 2021.

An yarda da BRUKINSA a cikin alamomi da yankuna masu zuwa:

• Don kula da lymphoma na mantle cell (MCL) a cikin manya marasa lafiya waɗanda suka sami aƙalla magani ɗaya kafin (Amurka, Nuwamba 2019)^a;
• Don kula da MCL a cikin manya marasa lafiya waɗanda suka sami aƙalla jiyya guda ɗaya (China, Yuni 2020) ^b;
• Don maganin cutar sankarar lymphocytic na yau da kullun (CLL) ko ƙananan lymphoma lymphocytic (SLL) a cikin manya marasa lafiya waɗanda suka sami aƙalla magani ɗaya kafin (China, Yuni 2020) ^b;
• Don maganin sake dawowa ko MCL (Daular Larabawa ta Hadaddiyar Daular Larabawa, Fabrairu 2021);
• Don maganin Waldenström's macroglobulinemia (WM) a cikin manya marasa lafiya (Kanada, Maris 2021);
• Don kula da manya marasa lafiya tare da WM waɗanda suka sami aƙalla jiyya ɗaya kafin (China, Yuni 2021)^b;
• Don kula da MCL a cikin manya marasa lafiya waɗanda suka sami aƙalla magani guda ɗaya (Kanada, Yuli 2021);
• Don kula da MCL a cikin manya marasa lafiya waɗanda suka sami aƙalla magani guda ɗaya (Chile, Yuli 2021);
• Don kula da tsofaffi marasa lafiya tare da MCL waɗanda suka sami aƙalla magani ɗaya na baya (Brazil, Agusta 2021);
• Don kula da manya marasa lafiya tare da WM (Amurka, Agusta 2021);
• Don kula da tsofaffi marasa lafiya tare da ƙananan yanki na lymphoma (MZL) waɗanda suka karɓi aƙalla tsarin tushen-CD20 (Amurka, Satumba 2021)*;
• Don kula da tsofaffi marasa lafiya tare da MCL waɗanda suka karɓi aƙalla magani ɗaya na baya (Singapore, Oktoba 2021);
• Don kula da MCL a cikin marasa lafiya waɗanda suka sami aƙalla jiyya guda ɗaya (Isra'ila, Oktoba 2021);
• Don kula da manya marasa lafiya tare da WM waɗanda suka karɓi aƙalla magani ɗaya kafin, ko a layin farko na jiyya ga marasa lafiya waɗanda basu dace da chemo-immunotherapy (Australia, Oktoba 2021);
• Don kula da manya marasa lafiya tare da MCL waɗanda suka karɓi aƙalla jiyya ɗaya kafin (Ostiraliya, Oktoba 2021);
• Don kula da tsofaffi marasa lafiya tare da MCL waɗanda suka sami aƙalla magani ɗaya na baya (Rasha, Oktoba 2021);
• Don maganin lymphoma na mantle cell (MCL) a cikin manya marasa lafiya waɗanda suka sami aƙalla magani ɗaya kafin (Saudi Arabia, Nuwamba 2021); kuma
• Don kula da manya marasa lafiya tare da WM waɗanda suka karɓi aƙalla magani ɗaya kafin magani ko jiyya na farko na marasa lafiya waɗanda basu dace da chemo-immunotherapy (Ƙungiyar Tarayyar Turai, Nuwamba 2021).

Farashin Brukinsa a Indiya

The Kudin Brukinsa capsule na baka 80 MG yana tsakanin $ 3500-4000 don samar da 120 capsules, dangane da kantin magani da kuke ziyarta.

Zan iya siyan Brukinsa akan layi?

Ee, zaku iya siyan Brukinsa akan layi. Yawancin kantin magani na kan layi suna siyarwa akan layi amma tare da ingantattun takaddun magunguna.

Don ƙarin bayani a kira, saƙo ko WhatsApp +91 961588 1588.

Da fatan a danna nan Don rubuta bayanin Brukinsa.